RARE DISEASES, COMPLEX CONDITIONS, ONE UNWAVERING COMMITMENT

Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare, acquired hematologic disorder caused by uncontrolled activation of the complement system, leading to chronic intravascular hemolysis, thrombosis, and bone marrow failure. The disease is associated with substantial morbidity and reduced survival without appropriate long-term management.

Atypical Hemolytic Uremic Syndrome (aHUS) is a rare, life-threatening thrombotic microangiopathy driven by dysregulation of the alternative complement pathway. It primarily affects the kidneys and may lead to multi-organ involvement, making early diagnosis and appropriate disease management critical.

Neuromyelitis Optica Spectrum Disorder (NMOSD) is a rare autoimmune disease of the central nervous system characterized by severe, recurrent inflammatory attacks affecting the optic nerves and spinal cord. Relapses are often associated with permanent neurological disability, highlighting the importance of effective long-term disease control.

Gaucher Disease is a rare inherited lysosomal storage disorder caused by deficiency of the enzyme glucocerebrosidase, leading to progressive accumulation of glucosylceramide in multiple organs. Type 1 presents with systemic involvement, while Type 3 is associated with chronic neurological manifestations

Refractory generalized myasthenia gravis is a rare and severe autoimmune neuromuscular disorder characterized by persistent muscle weakness and fatigability despite standard therapies. Complement-mediated damage at the neuromuscular junction plays a key role in disease severity and functional impairment.